Piermont Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $1.34M | Buy |
39,950
+800
| +2% | +$26.9K | 0.64% | 84 |
|
|
2018
Q3 | $1.65M | Sell |
39,150
-5,974
| -13% | -$252K | 0.66% | 87 |
|
|
2018
Q2 | $1.44M | Buy |
45,124
+1,800
| +4% | +$57.6K | 0.44% | 104 |
|
|
2018
Q1 | $2.15M | Buy |
43,324
+5,040
| +13% | +$251K | 0.72% | 52 |
|
|
2017
Q4 | $2.06M | Sell |
38,284
-1,540
| -4% | -$83K | 0.68% | 67 |
|
|
2017
Q3 | $2.31M | Hold |
39,824
| – | – | 0.76% | 52 |
|
|
2017
Q2 | $1.97M | Sell |
39,824
-10,176
| -20% | -$502K | 0.56% | 65 |
|
|
2017
Q1 | $2.17M | Sell |
50,000
-3,535
| -7% | -$154K | 0.52% | 81 |
|
|
2016
Q4 | $2.62M | Sell |
53,535
-3,604
| -6% | -$176K | 0.6% | 65 |
|
|
2016
Q3 | $2.73M | Sell |
57,139
-23,349
| -29% | -$1.12M | 0.65% | 58 |
|
|
2016
Q2 | $4.32M | Buy |
80,488
+66,788
| +488% | +$3.58M | 1.12% | 2 |
|
|
2016
Q1 | $613K | Sell |
13,700
-300
| -2% | -$13.4K | 0.2% | 126 |
|
|
2015
Q4 | $534K | Sell |
14,000
-1,240
| -8% | -$47.3K | 0.17% | 134 |
|
|
2015
Q3 | $485K | Hold |
15,240
| – | – | 0.16% | 134 |
|
|
2015
Q2 | $503K | Sell |
15,240
-500
| -3% | -$16.5K | 0.15% | 167 |
|
|
2015
Q1 | $648K | Buy |
15,740
+5,360
| +52% | +$221K | 0.2% | 126 |
|
|
2014
Q4 | $423K | Sell |
10,380
-140
| -1% | -$5.71K | 0.15% | 114 |
|
|
2014
Q3 | $386K | Buy |
10,520
+4,690
| +80% | +$172K | 0.15% | 114 |
|
|
2014
Q2 | $270K | Hold |
5,830
| – | – | 0.11% | 109 |
|
|
2014
Q1 | $240K | Hold |
5,830
| – | – | 0.12% | 111 |
|
|
2013
Q4 | $222K | Buy |
+5,830
| New | +$222K | 0.11% | 112 |
|